Quality of life in ankylosing spondylitis

##plugins.themes.academic_pro.article.sidebar##

Published Apr 1, 2011
Download
pdf
Vol. 89 No. 4 (2011): Issue Apr 2011

##plugins.themes.academic_pro.article.main##

Mohamed Younes
Anis Jalled
Zohra Aydi
Kaouthar Younes
Mahbouba Jguirim
Saoussen Zrour
Zohra Ben Salah
Ismail Béjia
Mongi Touzi
Naceur Bergaoui

Abstract

Background: Ankylosing Spondylarthritis (AS) involves by its frequency and its repercussion on the functional capacity an important handicap and deterioration of the patients quality of life.
Aims: To evaluate the handicap and the quality of life during the AS and to seek the predictive factors of the deterioration of this quality of life.
Methods: A prospective study relating to 50 patients recruited in the
Department of Rheumatology of F. B. Hospital of Monastir during 6 months period (Mars to September 2008). The studied parameters were the quality of life evaluated by a specific sore (ASQOL) and a generic score (SF-12). Also the physical, social and economic felt handicap was evaluated using a qualitative scale. Predictive factors (clinical, biological and radiological) of the quality of life were carried out.
Results: Our patients are divided in 42 men and 8 women with an average age of 38.9 ± 10.7 years. The average duration of AS is of 11.9 ± 7.6 years. The average of ASQOL is of 11.9 ± 4 (extremes: 0- 17). The average of physical SF12 is of 29.8 ± 6 (21.7-53.2) and of mental SF–12 of 35.3± 6.6 (22.5-55.8). The physical, social and economic felt handicap was considered to be average or important in respectively 88%, 72% and 86% of the cases. The predictive factors of a high ASQOL (faded quality of life) are absence of occupation, high BASMI, a high number of painful articulations and high BASFI, BASDAI, BASG, BASRI and EVA total pain. The factors associated to the alteration of the quality of life according to SF-12'S are male sex, professional statute, high number of painful articulations and
high BASDAI, BASFI and BASRI.
Conclusion: Our study shows the important deterioration of the quality of life in AS patients. The existence of the predictive factors of quality of life primarily related to the functional capacity of the patients and to the disease activity implicates an early and adequate disease management in order to decrease this repercussion.

Keywords:

Ankylosing Spondylarthritis, quality of life, handicap, predictive factors

##plugins.themes.academic_pro.article.details##

References

  1. Koblet G, Andlin P, Maksymowych WP. Cost and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 2006; 33: 289-95.
  2. Ozgul A, Peker F, Taskaynatan MA, Tan AK, Dincer K, Kalyon TA. Effect of anykylosing spondylitis on health-related of life and different aspects of social life in young patients. Clin Rheumatol 2006; 25:168-74.
  3. Calin A, Garrett S, Whitelock L, Kennedy G, O'hea J, Mallorie P. A new approach to defining functional ability in Ankylosing Spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281-5.
  4. Heikkilä S, Viitanen JV, Kautiainen H, Kauppi M. Functional long- term changes with spondylarthropathy. Clin Rheumatol 2002; 21:119-22.
  5. Helliwell PS, Marzo-ortega H, Tennant A. Comparaison of a disease - specific and a generic instrument to measuring healthrelated quality of life in ankylosing spondylitis. Arthritis Rheum 2002; 46: 3098.
  6. Spoorenberg A, Van der Heijde D, de Klerk E, Dougados M, de vlam K, Mielants H. A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of Ankylosing Spondylitis. J Rheumatol 1999; 26: 961-5.
  7. Tam LS, Chan KY, LI EK. The influence of ilness and variables associated with functional limitations in chinese patients with ankylosing spondylitis. J Rheumatol 2007, 34: 1032-9.
  8. Guillemin F, Bruno C, Urlacher F, Vançon G, Pourel J. Quality of life in Ankylosing Spondylitis: Validation of the Ankylosing Spondylitis Arthritis Impact Measurement Scales 2, a Modified Arthritis Impact Measurement Scales Questionnaire. Arthritis Care Res 1999; 12: 157-62.
  9. Ariza-ArizaR, Cruz BH, Sarabia FN. Physical function and Health - Related Quality of Life of Spanish Patients with Ankylosing Spondylitis. Arthritis Rheum 2003; 49: 483-87.
  10. Chamberlain MA. Socioeconomic effects of Ankylosing Spondylitis in females: a comparison of 25 women with 25 males subjects. Int Rehabil Med. 1983; 5: 149-53.
  11. Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ. Development of the ASQol: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003; 62: 20- 26.
  12. Bal S, Bal K, Turan Y et al. Sexual functions in ankylosing spondylitis. Rheumatol Int. 2010 [Epub ahead of print].
  13. Challier B, Urlacher F, Vançon G, Lemelle I, Pourel J, Guillemin F. Is quality of life affected by season and weather conditions in ankylosing spondylitis? Clin Exp Rheumatol. 2001; 19:277-81.
  14. Boonen A, Van der Heijde D, Llandewe R, Guillemin F, Spoorenberg A, Schouten H. Costs of ankylosing spondylitis in three European countries: The patient's perspective. Ann Rheum Dis 2003; 62: 741-47.
  15. Dernis-Labous E, MessowM, Dougados M. Assessment of fatigue in the management of patients with ankylosing spondylitis. J Rheumatol 2003; 42: 1523-28.
  16. Doran MF, Brophy S, MacKay K, Taylor G, Calin A. Predictors of long term outcome in ankylosing spondylitis. J Rheumatol 2003; 30:316-20.
  17. Falkenbach A. Disability motivates patients with ankylosing spondylitis for more frequent physical exercise. Arch Phys Med Rehabil 2003; 84: 325-31.
  18. Jones SD, Koh WH, Steiner A, Garrett SL, Calin A. Fatigue in Ankylosing Spondylitis: Its prevalence and relationship to disease activity, sleep and other factors. J Rheumatol 1996; 23: 487-90.
  19. Calin A, Nackache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Outcome variables in Ankylosing Spondylitis: Evaluation of their relevance and discriminant capacity. J Rheumatol 1999; 26: 975-9.
  20. Van der Heijde D, van der Linden S, Bellamy N, Calin A, Dougados M, Khan MA. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol 1999; 26: 945-47.
  21. Da Costa D, Drista M, Ring A, Fitzcharles MA. Mental health status and leisure-time physical activity to fatigue intensity in patients with spondylarthropathy. Arthritis Rheum 2004; 51: 1004-8.
  22. Tubergen AV, Coenen J, Landdewé R et al. Assessment of fatigue patients in with ankylosing spondylitis: A psychometric analysis. Arthritis Rheum 2002; 47: 8-16.
  23. Baysal O, Durmufl B, Ersoy Y et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int 2010 [Epub ahead of print].
  24. Reilly MC, Gooch KL, Wong RL, Kupper H, van der Heijde D. Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rheumatology 2010; 49:812-9.
  25. Kiltz U, van der Heijde D. Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis. Clin Exp Rheumatol. 2009;27 (4 Suppl 55):S108-11.
  26. Ozdemir O. Quality of life in patients with ankylosing spondylitis: relationships with spinal mobility, disease activity and functional status. Rheumatol Int. 2010 [Epub ahead of print].
  27. Singh JA, Strand V. Spondyloarthritis is associated with poor function and physical health-related quality of life. J Rheumatol. 2009; 36:1012-20.
  28. Ward MM. Outcome measurement: health status and quality of life. Curr Opin Rheumatol 2004, 16: 96-101.
  29. Dougados M, Gueguen A, Nackache JP, Velicitat P, Zeidler H, Veys E. Clinical Relevance of C-Reactive Protein in axial Involvement of Ankylosing Spondylitis. J Rheumatol 1999; 26: 971-4.
  30. Amor B, Sandos R, Nuhal R, Listrat V, Dougados M. Predictive factors for long term outcome of spondyloarthropathie. J Rumathol 1994, 21: 1883-7.
  31. Robertson LP, Davis MJ. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology 2004; 43:1565-8.
  32. Viitanen JV, Heikkila S. Functional changes in patients with spondylarthropathy. A controlled trial of the effects of short-term rehabilitation and 3-year follow-up. Rheumatol Int 2001; 20: 211-4.
  33. Boonen A. Socioeconomic consequences of ankylosing spondylitis. Clin Exp Rheumatol 2002; 20 (6 suppl 28): s23-6.
  34. Cheung PP, Tymms KE, Wilson BJ et al. Infliximab in severe active spondylitis with spinal ankylosis. Intern Med J 2008; 38:396-401.
  35. Zhu TY, Tam LS, Lee VW, et al. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong. Rheumatology 2008; 47:1422-5.